An apple-flavoured phenylbutazone powder for the UK Equine market has been launched by Chanelle Vet UK.
Chanazone is indicated for the treatment of musculoskeletal conditions in the horse where relief from pain and a reduction in the associated inflammation is required, particularly where continued mobility is desired.
The product is available in packs of 100 × 5g sachets – each containing 1g of phenylbutazone.
Chanelle Vet UK commercial manager Gareth Carr said: “Chanazone is a fantastic addition to our range of high quality and affordable generic equine products.
“We have a very strong product portfolio, which is growing year on year. We are anticipating gaps in the market and striving to provide veterinary surgeons with innovative alternatives at affordable prices.”
Contact your local key account manager for further information.